Herbal Monograph
Fennel
Foeniculum vulgare Mill.
Apiaceae (Umbelliferae)
Premier aromatic carminative and antispasmodic for digestive complaints, infa...
Overview
Plant Description
Erect, glaucous, aromatic perennial herb (often cultivated as an annual or biennial), growing 1-2.5 m tall with a stout, branching, finely grooved stem. The entire plant is strongly aromatic with a characteristic anise-like scent. Leaves are alternate, 3-4 times pinnately compound, with filiform (thread-like) segments 0.5-2.5 cm long and 0.5 mm wide, giving the foliage a feathery, dill-like appearance. Basal leaves are large (up to 30 cm) with sheathing petiole bases; upper leaves become progressively reduced. Flowers are small, yellow, 5-petaled, arranged in large compound umbels 5-15 cm in diameter with 15-25 rays and no involucre or involucel (absence of bracts is a key identification feature distinguishing fennel from some toxic Apiaceae). Fruit is an oblong-elliptical cremocarp (schizocarp), 4-10 mm long, 1.5-3 mm wide, splitting into two mericarps each with 5 prominent ridges and 4 vittae (oil canals) on the dorsal surface and 2 on the commissural surface. Taproot is stout, fusiform, and fleshy. Two principal varieties are recognized in pharmacopeial use: var. vulgare (bitter fennel) and var. dulce (sweet fennel or Florence fennel), which differ in essential oil composition and morphology.
Habitat
Thrives in full sun on dry, well-drained, calcareous or sandy soils. Drought-tolerant once established. Prefers warm, sheltered positions. Grows along roadsides, waste ground, field margins, rocky slopes, and coastal cliffs in its native range. Naturalizes readily in Mediterranean-type climates and has become invasive in some regions, particularly coastal California and parts of Australia. Tolerates poor soils but produces higher essential oil content in moderately fertile conditions.
Distribution
Native to the Mediterranean basin and southern Europe, from Portugal and Morocco east to Turkey and Iran. Widely naturalized throughout temperate and subtropical regions worldwide, including western and central Europe, the Americas (particularly California, where it is an invasive species), South America (Argentina, Brazil), southern Africa, Australia, New Zealand, and parts of Asia. Major commercial production occurs in Egypt, India, China, Turkey, Syria, Morocco, Romania, Bulgaria, and Hungary. Widely cultivated in home gardens globally.
Parts Used
Fruit (Foeniculi fructus — commonly referred to as 'fennel seed')
Preferred: Dried whole fruit for infusion (freshly crushed immediately before use to release volatile oils); essential oil by steam distillation; tincture; fluid extract
The dried ripe fruit (cremocarp) is the primary medicinal part and is the subject of Commission E, EMA, ESCOP, and European Pharmacopoeia monographs. The term 'seed' is a botanical misnomer — the part used is technically the fruit (schizocarp), which splits into two mericarps. The volatile oil is concentrated in vittae (oil canals) within the pericarp. Two pharmacopeial varieties are distinguished: Foeniculi amari fructus (bitter fennel fruit, var. vulgare) and Foeniculi dulcis fructus (sweet fennel fruit, var. dulce). Bitter fennel fruit contains higher fenchone and estragole levels; sweet fennel fruit contains predominantly trans-anethole with very low fenchone and estragole. The European Pharmacopoeia specifies minimum essential oil content and limits for estragole content.
Essential oil (Foeniculi aetheroleum)
Preferred: Essential oil diluted in carrier oil for external use; encapsulated or in honey for internal use; component of compound preparations (e.g., fennel honey, gripe water)
Steam-distilled from crushed ripe fennel fruits. Bitter fennel essential oil (Foeniculi amari fructus aetheroleum) and sweet fennel essential oil (Foeniculi dulcis fructus aetheroleum) are distinguished in pharmacopeial standards. The essential oil is used both internally and externally in phytotherapy. Due to the concentrated estragole content (a genotoxic compound), the EMA HMPC has issued restrictions on essential oil use, particularly regarding duration of use and vulnerable populations (children, pregnant women). The essential oil is considerably more potent than the whole herb and requires careful dosing.
Root (Foeniculi radix)
Preferred: Decoction (historical use)
The root was listed in older pharmacopeias as one of the 'five opening roots' (cinq racines apéritives) of traditional European pharmacy, alongside asparagus, celery, butcher's broom, and parsley root. Used traditionally as a diuretic and for urinary tract support. Not included in modern Commission E or EMA monographs. Use is historical and largely obsolete in current Western herbal practice.
Key Constituents
Volatile oil (essential oil)
The volatile oil fraction is the primary driver of fennel's carminative, antispasmodic, and expectorant activity. trans-Anethole and fenchone are the principal active constituents. The essential oil content of fennel fruit (2-6%) is substantially higher than most other medicinal herbs, making fennel an exceptionally potent aromatic carminative. The antispasmodic effect is mediated through inhibition of smooth muscle calcium channels. Commission E, ESCOP, and EMA all identify the volatile oil as the primary active fraction. Sweet fennel is preferred for pediatric use due to lower estragole and fenchone content.
Flavonoids
The flavonoid fraction contributes antioxidant and mild anti-inflammatory activity. Flavonoids are extracted in both aqueous and hydroalcoholic preparations. Their contribution to fennel's overall therapeutic effect is considered secondary to the volatile oil fraction but may contribute to the hepatoprotective and antioxidant activity observed in some experimental studies.
Coumarins and furanocoumarins
The coumarin and furanocoumarin content of fennel fruit is pharmacologically minor at standard doses. Furanocoumarins are present at levels far below those in known photosensitizing Apiaceae (e.g., Heracleum, Ammi). No clinical reports of photosensitivity from fennel use at standard doses.
Fatty acids and sterols
The fixed oil fraction is not considered a primary therapeutic driver but provides nutritional fatty acids. Petroselinic acid is of pharmacological interest for its anti-inflammatory properties. The fatty acid composition is relevant to the quality and stability of fennel seed oil preparations.
Other constituents
Minor constituents contributing ancillary antioxidant and nutritional properties. The mineral content is relevant to drug interaction considerations (chelation of fluoroquinolone antibiotics).
Herbal Actions
Relieves intestinal gas and bloating
Fennel's most established and clinically important action. Relieves intestinal gas, bloating, and distension through a combination of smooth muscle relaxation (antispasmodic effect of trans-anethole and fenchone), stimulation of gastrointestinal motility, and possible effects on gas bubble surface tension. Commission E approved for 'dyspeptic complaints such as mild, spasmodic disorders of the gastrointestinal tract, feeling of fullness, and flatulence.' ESCOP and EMA concur. The BHP classifies fennel as a carminative. Fennel is one of the 'three carminative seeds' of traditional European pharmacy alongside anise and caraway.
[1, 2, 3, 4, 7]Relieves smooth muscle spasm
Relaxes smooth muscle, particularly in the gastrointestinal tract and bronchioles. The mechanism involves inhibition of store-operated calcium channels in smooth muscle cells, reducing acetylcholine-, histamine-, and serotonin-induced contractions. Both the volatile oil (trans-anethole, fenchone) and aqueous extract demonstrate spasmolytic activity in isolated smooth muscle preparations. This action underpins the use in infant colic, abdominal cramping, and as an adjunct in irritable bowel syndrome.
[1, 2, 5, 12]Stimulates ciliary motility and increases secretion of respiratory tract mucus, facilitating expectoration of viscous secretions. Commission E approved for 'catarrh of the upper respiratory tract.' The secretolytic action is attributed primarily to trans-anethole and fenchone. ESCOP confirms therapeutic use for catarrh of the upper respiratory tract. Bitter fennel (higher fenchone) is considered more expectorant than sweet fennel.
[1, 2, 3, 4]Promotes breast milk production
Traditional use for promoting lactation documented across multiple cultural traditions (European, Ayurvedic, Middle Eastern). The galactagogue effect is attributed to the estrogenic activity of trans-anethole, which may act on dopamine receptors in a manner that increases prolactin secretion. One small study showed increased serum prolactin after fennel administration. However, the LactMed database (NIH) notes that clinical evidence is limited, and the Cochrane review of galactagogues found very uncertain evidence for fennel's efficacy in increasing milk volume. Traditional use is well documented but clinical proof remains weak.
[4, 5, 14]Reduces inflammation
Demonstrated anti-inflammatory activity in multiple experimental models. Anethole has shown inhibition of TNF-alpha-induced NF-kB activation and inflammatory cytokine production. The volatile oil and aqueous extracts reduce edema in carrageenan-induced paw edema models. Clinical relevance at standard oral doses is primarily in the gastrointestinal tract (reducing mucosal inflammation) and respiratory tract.
[5, 12]trans-Anethole and its polymers (dianethole, photoanethole) have demonstrated estrogenic activity in experimental models, including uterotropic assay in rodents. The estrogenic potency is weak relative to endogenous estradiol. This activity is proposed to underlie both the galactagogue and emmenagogue traditional uses. Clinical significance at standard doses remains debated; the estrogenic effect may be relevant in traditional applications for dysmenorrhea and menopausal symptoms but is also the basis for pregnancy cautions.
[5, 12, 13]Kills or inhibits the growth of microorganisms
The essential oil demonstrates moderate in vitro activity against Gram-positive bacteria, some Gram-negative species, and fungi (Candida spp.). trans-Anethole and fenchone both contribute to antimicrobial activity. Activity is moderate and insufficient as sole antimicrobial treatment, but may contribute to the overall efficacy of fennel in respiratory and gastrointestinal conditions.
[2, 12]Traditional use as a mild diuretic is documented in older European pharmacopeias and in Ayurvedic medicine. Fennel root was historically considered one of the 'five opening roots' for urinary tract support. The diuretic effect of the fruit is mild and not a primary clinical indication in modern practice. Not confirmed by Commission E or EMA.
[4]Therapeutic Indications
gastrointestinal
Dyspeptic complaints (flatulence, bloating, fullness)
Commission E approved indication: 'Dyspeptic complaints such as mild, spasmodic disorders of the gastrointestinal tract, feeling of fullness, flatulence.' ESCOP and EMA confirm this as a well-established traditional use. The carminative and antispasmodic actions of the volatile oil directly address the symptoms of functional dyspepsia. First-line herbal indication for fennel.
[1, 2, 3]Infantile colic
Alexandrovich et al. (2003) RCT of 125 infants found fennel seed oil emulsion eliminated colic (Wessel criteria) in 65% of treated infants vs. 23.7% placebo (P<0.01, NNT=2). A systematic review and meta-analysis confirmed significant improvement in crying duration. Fennel is a traditional component of gripe water formulations. The EMA acknowledges traditional use in children over 4 years; use in infants under 4 years is not covered by the EMA monograph due to estragole safety concerns, though traditional use in this population is long-standing. Sweet fennel preparations with low estragole content are preferred for pediatric use.
[2, 9, 10]Irritable bowel syndrome (adjunctive)
The antispasmodic and carminative actions provide pharmacological rationale for use in IBS, particularly the bloating-predominant subtype. Fennel is commonly included in herbal formulas for IBS in clinical practice. Limited direct clinical evidence; indication is based on traditional use and the known antispasmodic pharmacology. Often combined with peppermint and chamomile.
[4, 5]Loss of appetite
Traditional use as an appetite stimulant, particularly in convalescence and in elderly patients with poor appetite. The aromatic volatile oil stimulates gastric secretion and appetite. Documented in traditional European herbalism and Ayurvedic practice. Not a primary Commission E or EMA indication but consistent with the broader digestive profile.
[4]Respiratory System
Upper respiratory catarrh (productive cough with viscous mucus)
Commission E approved indication: 'Catarrh of the upper respiratory tract.' ESCOP confirms therapeutic use for 'catarrh of the upper respiratory tract.' The secretolytic (expectorant) action of the volatile oil, particularly fenchone, thins viscous bronchial secretions and stimulates ciliary clearance. Bitter fennel is preferred for respiratory indications due to higher fenchone content. Used as infusion, essential oil inhalation, or fennel honey (especially in pediatrics).
[1, 2, 3]Bronchitis (mild, as adjunctive expectorant)
Traditional use in acute and chronic bronchitis as an expectorant and mucolytic adjunct. Combined with other expectorant herbs (thyme, plantain, liquorice) in traditional European cough formulas. Fennel honey (Mel Foeniculi) is a traditional European pediatric preparation for cough.
[3, 4]Reproductive System
Dysmenorrhea (menstrual cramping)
The EMA notes traditional use for 'symptomatic treatment of minor spasm (cramps) associated with menstrual periods.' The antispasmodic action on uterine smooth muscle, combined with mild estrogenic activity of anethole, provides pharmacological rationale. Several small clinical trials (including Modaress Nejad & Asadipour, 2006) have shown fennel extract comparable to mefenamic acid for primary dysmenorrhea pain relief, though methodological quality is variable.
[2, 5, 12]Promotion of lactation (galactagogue)
Traditional galactagogue use is documented across European, Ayurvedic, and Middle Eastern traditions for centuries. Pliny and Dioscorides noted fennel's ability to promote breast milk. The mechanism is proposed to involve mild estrogenic activity of anethole derivatives affecting prolactin secretion. However, the LactMed database notes limited and low-quality clinical evidence. One study showed increased serum prolactin with fennel but did not measure milk volume. The Cochrane review found very uncertain evidence. Excessive maternal consumption of fennel-containing herbal teas has been associated with toxicity in two breastfed neonates (case report), warranting moderation in dosing.
[4, 5, 14]ophthalmic
Conjunctivitis and eye irritation (traditional external use)
Ancient use as an eye wash for conjunctivitis and eye inflammation dates to Dioscorides and Pliny, who recorded fennel's reputation for improving eyesight. Pliny advocated fennel for 'problems with the eyes and sight.' This traditional use persists in some European folk medicine practices (fennel infusion as an eye compress). Not supported by modern clinical evidence. Non-sterile herbal preparations applied to the eye carry infection risk; this use is not recommended in modern practice without appropriate sterile formulation.
[4]Energetics
Temperature
warm
Moisture
slightly dry
Taste
Tissue States
cold/depression, damp/stagnation, wind/tension
Fennel is warming and mildly drying in Western energetic assessment. Its pronounced sweetness (from trans-anethole) reflects its nourishing, relaxant quality, while its pungency indicates the aromatic, diffusive, and circulatory-stimulating actions. The mild bitterness (more pronounced in var. vulgare) contributes to digestive stimulation. Fennel is specifically indicated for cold, damp digestive states with gas, bloating, and cramping — the classic presentation of 'wind' in the gut. It warms a cold, sluggish digestion without being overly heating or irritating. In Ayurvedic terms, fennel is one of the few warming spices that does not aggravate Pitta, making it suitable for all three doshas (tridoshic). Rasa: madhura (sweet), katu (pungent), tikta (bitter). Virya: slightly ushna (warming). Vipaka: madhura (sweet post-digestive effect).
Traditional Uses
Greco-Roman classical medicine
- Digestive aid for flatulence and stomach complaints
- Promotion of breast milk (galactagogue)
- Eye medicine — fennel gum and juice applied externally for eye diseases
- Diuretic for kidney and bladder conditions
- Remedy for snake bites and poisoning (Pliny)
- Appetite suppressant (associated with the Greek 'marathron' from 'maraino,' to grow thin)
"Dioscorides (De Materia Medica, Book III) records fennel (marathron) as a diuretic beneficial for diseases of the kidney and bladder, and notes fennel gum as 'a more effective eye medicine than the plant juice.' Pliny the Elder (Natural History, Book XX) considers fennel a remedy for approximately twenty-two conditions, particularly advocating its use for problems of the eyes and sight. Hippocrates, Pliny, and Dioscorides all documented fennel's ability to soothe digestion and promote breast milk production. The name 'marathron' derives from the Greek 'maraino' (to grow thin), reflecting the ancient belief that fennel suppressed appetite."
European traditional herbalism
- Carminative for flatulence, colic, and digestive discomfort
- Expectorant for coughs and bronchial congestion
- Galactagogue for nursing mothers
- Ingredient in gripe water for infant colic
- Component of the 'four hot seeds' (quatuor semina calida maiora) — fennel, anise, caraway, coriander
- Fennel root as one of the 'five opening roots' (cinq racines apéritives) for urinary support
- Emmenagogue for delayed menstruation
"Hoffmann (2003): 'Fennel is one of the best herbs for digestive problems. It relieves flatulence, stimulates appetite and digestion, and is well suited for treating colic in infants. Due to its aromatic nature, it has the potential to aid in stimulating appetite as well as digestion. It can also be used as an expectorant for coughs and bronchial congestion.' Fennel was included in medieval European formularies as one of the four greater hot seeds (semina calida maiora) alongside anise, caraway, and coriander, used universally for digestive complaints. Gerard's Herbal (1597) and Culpeper's Complete Herbal (1653) both recommend fennel for flatulence, increasing breast milk, and improving eyesight."
Ayurvedic medicine (Shatapushpa / Saunf)
- Digestive stimulant (deepana) and carminative (pachana) for agni (digestive fire)
- Treatment for abdominal bloating, flatulence, and colic
- Galactagogue (stanyajanana) — promotes breast milk production via rasa dhatu
- Cooling digestive spice suitable for Pitta conditions
- Treatment for diarrhea and dysentery
- Support for eye health (chakshushya)
- Relief of cough, asthma, and respiratory congestion
"In Ayurveda, fennel (Saunf, also called Shatapushpa or Madhurika) is classified with Rasa: madhura (sweet), katu (pungent), tikta (bitter); Guna: laghu (light), rooksha (dry); Virya: slightly ushna (warming); Vipaka: madhura (sweet). It is described as one of the few warming spices that does not aggravate Pitta dosha, making it tridoshic and suitable for all constitutional types. Fennel is used to kindle agni (digestive fire) and aid proper digestion and assimilation. It has a specific action on rasa dhatu, promoting the flow of breast milk in nursing mothers. The Charaka Samhita and Sushruta Samhita both list fennel among digestive and carminative herbs."
[17]
German phytotherapy (Commission E / ESCOP)
- Internal: dyspeptic complaints (mild spasmodic GI disorders, fullness, flatulence)
- Internal: catarrh of the upper respiratory tract
- Pediatric: component of digestive and cough preparations for children
"Commission E approved fennel fruit internally for 'dyspeptic complaints such as mild, spasmodic disorders of the gastrointestinal tract, feeling of fullness, flatulence' and for 'catarrh of the upper respiratory tract.' ESCOP monograph on Foeniculi fructus confirms these indications: 'dyspeptic complaints such as mild, spasmodic gastro-intestinal ailments, bloating and flatulence and catarrh in the upper respiratory tract.' ESCOP adult dose: 5-7 g dried fruit daily; children over 4 years: 3-5 g daily."
Traditional Iranian (Persian) medicine
- Carminative and digestive aid
- Galactagogue for increasing breast milk
- Treatment for kidney stones and urinary complaints
- Eye health and vision improvement
- Antidote for poisons
- Menstrual regulation
"In traditional Iranian medicine, fennel (Razianeh) is one of the most widely used medicinal plants. It is considered warming and dry in temperament. Ibn Sina (Avicenna) in the Canon of Medicine describes fennel as beneficial for digestion, eyesight, increasing breast milk, and as a diuretic. Fennel has an extensive history in Persian pharmacy for both digestive and gynecological conditions."
[18]
Modern Research
Infantile colic — fennel seed oil emulsion
Randomized placebo-controlled trial evaluating fennel seed oil emulsion for the treatment of infantile colic.
Findings: Alexandrovich et al. (2003) randomized 125 infants aged 2-12 weeks with colic to fennel seed oil emulsion or placebo. Colic was eliminated (Wessel criteria: crying <9 hours/week) in 65% (40/62) of infants in the fennel group vs. 23.7% (14/59) in the placebo group (P<0.01). Absolute risk reduction was 41% (95% CI 25-57%), with a number needed to treat (NNT) of 2 (95% CI 2-4). No adverse effects were reported in either group.
Limitations: Single-center study. Short treatment duration (1 week). Concerns regarding estragole exposure in neonates have been raised since the study's publication. The EMA HMPC does not endorse fennel use in children under 4 years in its current monograph due to estragole safety concerns, though this specific study found no adverse effects. Replication in larger multicenter trials is needed.
[9]
Infantile colic — systematic review and meta-analysis
Systematic review and meta-analysis of fennel-containing interventions for infantile colic.
Findings: Perry et al. (2011) and subsequent meta-analyses identified multiple trials studying fennel or fennel-containing compounds for infantile colic. Four trials showed significant improvement in crying duration compared to control groups. Fennel alone or in combination with other herbal medicines (chamomile, lemon balm) was effective in reducing colic symptoms. The meta-analysis confirmed a statistically significant reduction in crying time.
Limitations: Included studies were small and of variable methodological quality. Heterogeneity in interventions (fennel alone vs. combination products), dosing, and outcome measures limits meta-analytic precision. The safety profile in neonates requires further evaluation given estragole concerns. The overall certainty of evidence was rated low to very low.
[10]
Antispasmodic mechanism — calcium channel inhibition
In vitro investigation of the spasmolytic mechanism of fennel essential oil on gastrointestinal smooth muscle.
Findings: Fennel essential oil and its major constituents (trans-anethole, fenchone) demonstrated dose-dependent relaxation of isolated smooth muscle preparations (guinea pig ileum, rabbit jejunum). The antispasmodic effect was found to be mediated through inhibition of store-operated calcium channels in smooth muscle cells, reducing contractions induced by acetylcholine, histamine, serotonin, and KCl. Anethole was the most active individual constituent. The mechanism is distinct from the anticholinergic pathway used by conventional antispasmodics.
Limitations: In vitro and ex vivo studies. Dose extrapolation to human clinical use is indirect. The relative contribution of individual volatile oil constituents to the overall spasmolytic effect of the whole essential oil requires further clarification.
[12]
Estrogenic activity of anethole
Investigation of the estrogenic properties of anethole and its polymers from fennel.
Findings: Albert-Puleo (1980) reviewed evidence for the estrogenic activity of anethole, proposing that anethole polymers (dianethole and photoanethole) rather than anethole itself are responsible for the observed estrogenic effects. These polymers demonstrated activity in the rodent uterotropic assay. The estrogenic potency is weak relative to estradiol. This activity provides a pharmacological rationale for traditional galactagogue and emmenagogue uses. However, the clinical significance of the estrogenic activity at standard oral fennel doses in humans remains uncertain.
Limitations: Animal models. The clinical relevance of weak phytoestrogenic activity at standard herbal doses is debated. More recent studies have not fully confirmed the polymer hypothesis. Human clinical data on fennel's estrogenic effect is limited.
[13]
Estragole genotoxicity and carcinogenicity assessment
EMA HMPC risk assessment of estragole in herbal medicinal products including fennel.
Findings: The HMPC concluded that estragole is a naturally occurring genotoxic carcinogen based on rodent data. The mechanism involves dose-dependent hepatic metabolic activation to 1'-hydroxyestragole sulfate, which binds DNA. However, the metabolic activation pathway operates predominantly at high doses (rodent carcinogenic doses 100-1000x estimated human exposure). At low exposure levels (1-10 mg/kg), the metabolic activation is minimal. The HMPC recommended that exposure to estragole should be kept as low as practically achievable, with particular caution in young children, pregnant women, and breastfeeding women. Duration of use of fennel preparations should be limited.
Limitations: Risk assessment based primarily on rodent data at doses far exceeding human dietary exposure. Extrapolation from high-dose rodent studies to low-dose human exposure involves significant uncertainty. No epidemiological evidence links fennel consumption at dietary or standard medicinal doses to cancer risk in humans. The risk-benefit balance is considered favorable for short-term use of fennel fruit preparations with controlled estragole content.
Comprehensive pharmacological review
Review of botany, phytochemistry, pharmacology, contemporary application, and toxicology of Foeniculum vulgare.
Findings: Badgujar et al. (2014) comprehensively reviewed the pharmacological evidence for fennel, documenting in vitro and in vivo evidence for antimicrobial, antiviral, anti-inflammatory, antimutagenic, antinociceptive, antipyretic, antispasmodic, antithrombotic, cardiovascular, hepatoprotective, hypoglycemic, hypolipidemic, and memory-enhancing properties. The review identified trans-anethole, fenchone, and estragole as the principal active constituents driving most pharmacological effects. Acute toxicity studies in rodents showed LD50 values of approximately 1326 mg/kg (oral) for fennel essential oil, indicating relatively low acute toxicity.
Limitations: Narrative review encompassing predominantly pre-clinical studies. Most pharmacological activities are demonstrated only in animal models or in vitro. Clinical translation to human therapeutic doses requires further investigation for many of the reported activities.
[12]
Preparations & Dosage
Infusion (Tea)
Strength: 1.5-2.5 g crushed dried fruit per 250 mL boiling water
Freshly crush 1-2 teaspoons (1.5-2.5 g) of dried fennel fruits immediately before preparation using a mortar and pestle or the back of a spoon to release the volatile oils. Pour 250 mL of freshly boiled water over the crushed fruits. Cover tightly (essential to retain volatile oils) and steep for 10-15 minutes. Strain and drink warm. For infants, a weaker infusion may be prepared using half the adult dose.
1.5-2.5 g crushed dried fruit per cup, 2-3 times daily. ESCOP recommends 5-7 g dried fruit daily in divided doses.
2-3 times daily, preferably after meals for digestive indications, or between meals for respiratory indications
EMA recommends limiting duration to 2 weeks for self-medication. If symptoms persist beyond 2 weeks, consult a healthcare professional.
Children over 4 years: 3-5 g dried fruit daily in divided doses (ESCOP). For younger children and infants: consult a qualified practitioner. Traditional pediatric dose is approximately 1-2 mL of weak fennel infusion (1 g per 150 mL) up to 3 times daily, though the EMA monograph does not cover use under 4 years due to estragole concerns.
Crushing the fruits immediately before infusion is essential to release volatile oils from the vittae. Pre-ground fennel loses volatile oil content rapidly. Covering the vessel during steeping prevents loss of volatile constituents by evaporation. The infusion extracts volatile oils, flavonoids, and water-soluble constituents. This is the most common traditional preparation and the form specified in most pharmacopeial monographs. Sweet fennel is preferred for pediatric use due to lower estragole and fenchone content.
Tincture
Strength: 1:5 dried fruit in 45-60% ethanol
Macerate dried crushed fennel fruits in 45-60% ethanol at a ratio of 1:5 for 2-4 weeks. Shake daily. Press and filter through fine filter paper.
2-4 mL of 1:5 tincture (in 45-60% ethanol), 3 times daily
3 times daily, after meals for digestive indications
2-4 weeks, then reassess
Not recommended for children under 12 years due to alcohol content. Use infusion or fennel honey preparations instead for pediatric patients.
The hydroalcoholic tincture extracts both volatile oil components and non-volatile constituents (flavonoids, coumarins, fixed oil). The BHP specifies a 1:5 tincture. Tincture is convenient for adult dosing and for inclusion in compound formulas with other carminative or antispasmodic herbs.
Essential Oil
Strength: Pure essential oil (sweet or bitter fennel); diluted 5-10% in carrier oil for topical use
For internal use: 1-2 drops of pharmaceutical-grade fennel essential oil on a sugar cube, in honey, or in an enteric-coated capsule. For external use: dilute 2-5 drops in 10 mL carrier oil for abdominal massage (clockwise direction for digestive complaints). For inhalation: add 3-5 drops to a bowl of hot water and inhale steam for respiratory congestion.
0.1-0.6 mL (approximately 2-12 drops) daily in divided doses for internal use (Commission E). EMA specifies 5-7.5 g fennel fruit daily (equivalent to 0.1-0.6 mL essential oil) for well-established use preparations.
2-3 times daily
Limit internal essential oil use to 2 weeks maximum (EMA recommendation). Avoid prolonged or habitual use due to estragole content.
Not recommended for internal essential oil use in children. The EMA HMPC does not recommend essential oil for children due to estragole content. External abdominal massage with diluted oil (1-2 drops in 20 mL carrier oil) is used traditionally for infant colic, though practitioner guidance is advised.
Essential oil is the most concentrated form and carries the highest estragole exposure risk. The HMPC classification of estragole as a genotoxic carcinogen means that essential oil use should be time-limited and avoided in vulnerable populations. Bitter fennel oil has higher fenchone and estragole than sweet fennel oil. Pharmaceutical-grade oil should meet European Pharmacopoeia specifications for trans-anethole content and estragole limits. Do not use undiluted on skin.
other
Strength: Fennel-infused honey
Fennel honey (Mel Foeniculi): Mix 1-2 g of crushed fennel fruit with 30 g of liquid honey. Allow to infuse for several days, then strain. Alternatively, add 1-2 drops of fennel essential oil to 100 g of honey and mix thoroughly. Administer by the teaspoon. This is a traditional European pediatric preparation for cough and mild digestive complaints.
1-2 teaspoons, 3 times daily
2-3 times daily, or as needed for cough
Short-term use (1-2 weeks)
Children over 1 year: 0.5-1 teaspoon, 2-3 times daily. Do not give honey to infants under 12 months (botulism risk from honey, not from fennel).
Fennel honey is a traditional and palatable preparation particularly suited to pediatric and elderly patients. The honey base provides demulcent action on the throat, complementing fennel's expectorant effect for cough. This preparation delivers a lower dose of volatile oil than the pure essential oil and is thus considered safer for occasional pediatric use. Widely used in German and Italian folk medicine.
[4]
Safety & Interactions
Class 2b
Not to be used during lactation (AHPA Botanical Safety Handbook)
Contraindications
Cross-reactive allergic responses may occur in individuals sensitized to other Apiaceae members (carrot, celery, caraway, dill, coriander) or to anethole-containing plants (anise, star anise). Allergic reactions including contact dermatitis and anaphylaxis have been reported rarely. Individuals with known celery-birch-mugwort-spice syndrome may be at increased risk.
Due to the demonstrated estrogenic activity of anethole and its polymers in experimental models, concentrated fennel preparations (essential oil, high-dose extracts) should be avoided in individuals with estrogen-receptor-positive breast cancer, endometriosis, or uterine fibroids as a precautionary measure. The clinical significance at standard herbal tea doses is uncertain, and dietary use of fennel as a food spice is generally not restricted. Sources disagree on the clinical relevance: Mills & Bone (2013) note the estrogenic potency is very weak, while the AHPA Botanical Safety Handbook recommends caution.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Fluoroquinolone antibiotics (ciprofloxacin, norfloxacin) (Fluoroquinolone antibiotics) | moderate | Divalent cations (calcium, magnesium, iron, zinc) in fennel fruit form chelation complexes with fluoroquinolone antibiotics, reducing their gastrointestinal absorption. Zhu et al. (2000) demonstrated in a rat model that concurrent fennel administration reduced ciprofloxacin Cmax by 83%, AUC by 48%, and urinary recovery by 43%. |
| CYP3A4 substrates (Various (calcium channel blockers, statins, cyclosporine, some antiretrovirals, etc.)) | theoretical | In vitro studies suggest fennel constituents may inhibit CYP3A4, potentially increasing plasma levels of drugs metabolized by this enzyme. The clinical significance at standard herbal doses is unknown. |
| Estrogen-containing medications (oral contraceptives, HRT) (Hormonal preparations) | theoretical | Fennel's mild estrogenic activity could theoretically potentiate or interfere with exogenous estrogen therapy. The phytoestrogenic potency is very weak relative to pharmaceutical estrogens. |
Pregnancy & Lactation
Pregnancy
possibly unsafe
Lactation
likely safe
PREGNANCY: AHPA classifies fennel essential oil as Class 2b (not to be used during pregnancy). Fennel fruit has traditional emmenagogue classification and demonstrated mild estrogenic activity from anethole. While fennel as a culinary spice in food amounts is generally considered safe during pregnancy, therapeutic doses (especially essential oil or concentrated extracts) should be avoided. No teratogenic effects have been reported in standard use, and epidemiological data does not suggest increased risk from dietary fennel consumption. The EMA recommends against use of fennel medicinal products during pregnancy due to insufficient safety data. LACTATION: Fennel has a centuries-old tradition as a galactagogue and is generally considered compatible with breastfeeding at standard doses. However, the LactMed database recommends using fennel in moderation during breastfeeding. A case report of neonatal toxicity from excessive maternal consumption of a fennel-containing herbal tea (combined with anise and other herbs) warrants caution regarding excessive intake. The EMA HMPC notes that estragole exposure via breast milk is a theoretical concern; therefore short-term use at standard doses is preferred.
Adverse Effects
References
Monograph Sources
- [1] Blumenthal, M., Busse, W.R., Goldberg, A., et al.. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council / Integrative Medicine Communications (1998) . ISBN: 978-0965555500
- [2] Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Foeniculum vulgare Miller subsp. vulgare var. dulce (Mill.) Batt. & Trab., fructus (Revision 1) and Assessment report on Foeniculum vulgare Miller subsp. vulgare var. vulgare / var. dulce, fructus. European Medicines Agency (2024)
- [3] ESCOP (European Scientific Cooperative on Phytotherapy). ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products — Foeniculi fructus. ESCOP / Thieme (2003) . ISBN: 978-1901964073
- [4] Hoffmann, D.. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press (2003) . ISBN: 978-0892817498
- [5] Mills, S., Bone, K.. Principles and Practice of Phytotherapy: Modern Herbal Medicine (2nd edition). Churchill Livingstone / Elsevier (2013) . ISBN: 978-0443069925
- [6] Gardner, Z., McGuffin, M. (eds.). American Herbal Products Association's Botanical Safety Handbook (2nd edition). CRC Press (2013) . ISBN: 978-1466516946
- [7] British Herbal Medicine Association. British Herbal Pharmacopoeia. BHMA (1983)
- [8] Committee on Herbal Medicinal Products (HMPC). Public statement on the use of herbal medicinal products containing estragole (Revision 1). European Medicines Agency (2023)
Clinical Studies
- [9] Alexandrovich, I., Rakovitskaya, O., Kolmo, E., et al.. The effect of fennel (Foeniculum vulgare) seed oil emulsion in infantile colic: a randomized, placebo-controlled study. Alternative Therapies in Health and Medicine (2003) ; 9 : 58-61 . PMID: 12868253
- [10] Perry, R., Hunt, K., Ernst, E.. Nutritional supplements and other complementary medicines for infantile colic: a systematic review. Pediatrics (2011) ; 127 : 720-733 . DOI: 10.1542/peds.2010-2098 . PMID: 21444591
- [11] Zhu, M., Wong, P.Y., Li, R.C.. Effect of oral administration of fennel (Foeniculum vulgare) on ciprofloxacin absorption and disposition in the rat. Journal of Pharmacy and Pharmacology (2000) ; 51 : 1391-1396 . PMID: 10678493
- [12] Badgujar, S.B., Patel, V.V., Bandivdekar, A.H.. Foeniculum vulgare Mill: A Review of Its Botany, Phytochemistry, Pharmacology, Contemporary Application, and Toxicology. BioMed Research International (2014) ; 2014 : 842674 . DOI: 10.1155/2014/842674 . PMID: 25162032
- [13] Albert-Puleo, M.. Fennel and anise as estrogenic agents. Journal of Ethnopharmacology (1980) ; 2 : 337-344 . DOI: 10.1016/S0378-8741(80)81015-4 . PMID: 6999244
- [14] National Institute of Child Health and Human Development. Fennel — Drugs and Lactation Database (LactMed). National Library of Medicine / NCBI Bookshelf (2024)
Traditional Texts
- [15] Dioscorides, P.. De Materia Medica (Book III). c. 65 CE. Various translations. (65)
- [16] Pliny the Elder. Naturalis Historia (Natural History, Book XX). c. 77 CE. Various translations. (77)
- [17] Frawley, D., Lad, V.. The Yoga of Herbs: An Ayurvedic Guide to Herbal Medicine (2nd edition). Lotus Press (2001) . ISBN: 978-0941524247
- [18] Mahboubi, M.. Foeniculum vulgare as Valuable Plant in Management of Women's Health. Journal of Menopausal Medicine (2019) ; 25 : 1-14 . DOI: 10.6118/jmm.2019.25.1.1 . PMID: 31080785
Pharmacopeias & Reviews
- [19] European Pharmacopoeia Commission. European Pharmacopoeia — Foeniculi amari fructus (Bitter Fennel Fruit) and Foeniculi dulcis fructus (Sweet Fennel Fruit). Council of Europe / EDQM (2023)
Last updated: 2026-03-02 | Status: review
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.